The few studies showing the response of those cells to pancreatic adenocarcinoma suggest that the immunity of CD4+ helper T cells in such neoplasm is directed toward a type Th2 suppressive immune response [30, 53, 54]. Here, CD4 is linked to pancreatic adenocarcinoma.